PWA
TXMD icon

Provenance Wealth Advisors’s TherapeuticsMD TXMD Stock Holding History

Provenance Wealth Advisors’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40 Hold
20
– – ﹤0.01% 411
2025
Q4 		$33 Hold
20
– – ﹤0.01% 418
2025
Q3 		$22 Hold
20
– – ﹤0.01% 436
2025
Q2 		$23 Hold
20
– – ﹤0.01% 420
2025
Q1 		$19 Hold
20
– – ﹤0.01% 539
2024
Q4 		$17 Hold
20
– – ﹤0.01% 554
2024
Q3 		$33 Hold
20
– – ﹤0.01% 597
2024
Q2 		$32 Hold
20
– – ﹤0.01% 515
2024
Q1 		$46 Hold
20
– – ﹤0.01% 541
2023
Q4 		$45 Hold
20
– – ﹤0.01% 593
2023
Q3 		$60 Buy
+20
New +$76 ﹤0.01% 481

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.29B AUM 38.13% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $250M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return